Voltron Therapeutics, Inc announces COVID-19 and pandemic preparedness presentation to congressional offices and agencies, including HHS, NIH, FDA, and DoD.
Presenters included VIC’s Mark C. Poznansky, MD, PhD, FRCP, FIDSA, Michael V. Callahan, MD, MSPH, DTM&H and Patrick M Reeves, PhD discussing state of the art vaccines for COVID-19 and variants.
“NEW YORK, April 13, 2021 (GLOBE NEWSWIRE) — Voltron Therapeutics, Inc. today announced that the Company presented to Congressional Offices and Agencies, including HHS, NIH, FDA and the DoD on Thursday April 8th. This follows dozens of recent one-on-one briefings with Congressional staffers.
Presentations focused on current challenges being faced by governments due to COVID-19 mutations and why further vaccine development and innovation, especially in vaccine platforms, is vital. This is not just true for COVID-19, but for emerging variants and future pandemic pathogens. Panelists also discussed a potential solution under development that is based on Self-Assembling Vaccine technology developed at Harvard and Massachusetts General Hospital’s Vaccine and Immunotherapy Center and licensed by Voltron. This technology is designed to ensure that the US is ready to protect both citizens and warfighters from existing, emerging and mutating pathogens.”
